A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Brompheniramine
Dinutuximab
The risk or severity of adverse effects can be increased when Budesonide is combined with Dinutuximab.
Brompheniramine
Blinatumomab
The risk or severity of adverse effects can be increased when Budesonide is combined with Blinatumomab.
Brompheniramine
Vedolizumab
The risk or severity of adverse effects can be increased when Budesonide is combined with Vedolizumab.
Brompheniramine
Obinutuzumab
The risk or severity of adverse effects can be increased when Budesonide is combined with Obinutuzumab.
Brompheniramine
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Budesonide is combined with Dimethyl fumarate.
Brompheniramine
Carfilzomib
The risk or severity of adverse effects can be increased when Budesonide is combined with Carfilzomib.
Brompheniramine
Teriflunomide
The risk or severity of adverse effects can be increased when Budesonide is combined with Teriflunomide.
Brompheniramine
Belimumab
The risk or severity of adverse effects can be increased when Budesonide is combined with Belimumab.
Brompheniramine
Eribulin
The risk or severity of adverse effects can be increased when Budesonide is combined with Eribulin.
Brompheniramine
Wortmannin
The risk or severity of adverse effects can be increased when Budesonide is combined with Wortmannin.
Brompheniramine
Pralatrexate
The risk or severity of adverse effects can be increased when Budesonide is combined with Pralatrexate.
Brompheniramine
Bendamustine
The risk or severity of adverse effects can be increased when Budesonide is combined with Bendamustine.
Brompheniramine
Belatacept
The risk or severity of adverse effects can be increased when Budesonide is combined with Belatacept.
Brompheniramine
Abetimus
The risk or severity of adverse effects can be increased when Budesonide is combined with Abetimus.
Brompheniramine
Mepolizumab
The risk or severity of adverse effects can be increased when Budesonide is combined with Mepolizumab.
Brompheniramine
Human interferon omega-1
The risk or severity of adverse effects can be increased when Budesonide is combined with Human interferon omega-1.
Brompheniramine
Briakinumab
The risk or severity of adverse effects can be increased when Budesonide is combined with Briakinumab.
Brompheniramine
Gallium nitrate
The risk or severity of adverse effects can be increased when Budesonide is combined with Gallium nitrate.
Brompheniramine
Glatiramer
The risk or severity of adverse effects can be increased when Budesonide is combined with Glatiramer.
Brompheniramine
Interferon alfa
The risk or severity of adverse effects can be increased when Budesonide is combined with Interferon alfa.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3